ArticleTranslational cancer research2026
Defining the biological boundaries of daratumumab monotherapy: long-term insights from the CENTAURUS trial in high-risk smoldering multiple myeloma.
Katsuhiro MiuraPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.